Conflict Of Interest Rules Removed In Draft Of House User Fee Bill
This article was originally published in The Tan Sheet
Executive Summary
Reforms would end waiver caps for conflicts of interest, but whether they will solve the problems patient groups and others have with the advisory committee selection process is unclear. In a discussion draft, FDA could issue as many waivers of financial conflicts as it chose.
You may also be interested in...
Regulatory News In Brief
Proposals to change supplement regs tabled in Senate; Senate wants firm sunscreen rule compliance date; 2012 sees rise in tainted sexual enhancement supplements.
Regulatory News In Brief
Proposals to change supplement regs tabled in Senate; Senate wants firm sunscreen rule compliance date; 2012 sees rise in tainted sexual enhancement supplements.
Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.